You're looking at Less Wrong's discussion board. This includes all posts, including those that haven't been promoted to the front page yet. For more information, see About Less Wrong.

CellBioGuy comments on The Growth of My Pessimism: Transhumanism, Immortalism, Effective Altruism. - Less Wrong Discussion

15 Post author: diegocaleiro 28 November 2015 11:07AM

You are viewing a comment permalink. View the original post to see all comments and the full post content.

Comments (74)

You are viewing a single comment's thread. Show more comments above.

Comment author: CellBioGuy 29 November 2015 04:38:37AM *  1 point [-]

They're honestly quite possibly just bullshitting about their grand plans. Theranos, that is. I wouldn't be surprised if they had some interesting ideas that they are utterly unprepared to follow through on and that they are massively overselling the importance and quality of.

Comment author: ChristianKl 29 November 2015 01:26:40PM 2 points [-]

Why would a company who doesn't trust into it's tech working explicitely lobby the FDA to test their products to make sure that the marketplace trusts them?

I don't think there a good reason that blood testing roughly didn't change much in price in the last 10 years while DNA sequencing got 10,000 as cheap. We good cheaper DNA sequencing because multiple companies focused on radically improving sequencing technology.

Having a direct to consumer marketplace where people know the price of testing before they buy it is likely very useful for the field to produce price competition that leads to the development of cheaper testing.

We don't need the price improvement of sequencing for blood test but having moore's law for it or half of moore's law would be a game changer. Do you think there are basic reasons why blood testing shouldn't be able to radically improve in price over time?